Epizyme, Inc., 325 Vassar Street, Cambridge, MA 02139, USA.
Future Med Chem. 2011 Sep;3(12):1491-501. doi: 10.4155/fmc.11.112.
Although drug-target interactions are commonly illustrated in terms of structurally static binding and dissociation events, such descriptions are inadequate to explain the impact of conformational dynamics on these processes. For high-affinity interactions, both the association and dissociation of drug molecules to and from their targets are often controlled by conformational changes of the target. Conformational adaptation can greatly influence the residence time of a drug on its target (i.e., the lifetime of the binary drug-target complex); long residence time can lead to sustained pharmacology and may also mitigate off-target toxicity. In this perspective, the kinetics of drug-target association and dissociation reactions are explored, with particular emphasis on the impact of conformational adaptation on drug-target residence time.
尽管药物-靶标相互作用通常以结构静态的结合和解离事件来表示,但这些描述不足以解释构象动力学对这些过程的影响。对于高亲和力的相互作用,药物分子与其靶标的结合和解离都受到靶标的构象变化的控制。构象适应可以极大地影响药物在靶标上的停留时间(即二元药物-靶标复合物的寿命);停留时间长可能导致持续的药理学作用,也可能减轻非靶标毒性。在这篇观点文章中,探讨了药物-靶标结合和解离反应的动力学,特别强调了构象适应对药物-靶标停留时间的影响。